Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 170

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Immunogenicity of aggregates of recombinant human growth hormone in mouse models

Open access
Fradkin, Amber Haynes, Carpenter, John F., Randolph, Theodore W.·2009·Journal of Pharmaceutical Sciences

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jps.21834

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 58

  1. Chi, 2003, Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation, Pharm Res, 20, 1325, 10.1023/A:1025771421906 · DOI · Paper page
  2. Braun, 1997, Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice, Pharm Res, 14, 1472, 10.1023/A:1012193326789 · DOI · Paper page
  3. Schellekens, 2003, The immunogenicity of biopharmaceuticals, Neurology, 61, S11, 10.1212/01.WNL.0000092358.51502.C0 · doi:10.1212/01.wnl.0000092358.51502.c0
  4. Wang, 2003, Correlation of rFVIII inactivation with aggregation in solution, Pharm Res, 20, 693, 10.1023/A:1023271405005 · DOI
  5. Moore, 1980, Role of aggregated human growth-hormone (Hgh) in development of antibodies to Hgh, J Clin Endocrinol Metab, 51, 691, 10.1210/jcem-51-4-691 · DOI · Paper page
  6. Ratner, 1990, Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates, Diabetes, 39, 728, 10.2337/diab.39.6.728 · DOI
  7. Porter, 2001, Human immune response to recombinant human proteins, J Pharm Sci, 90, 1, 10.1002/1520-6017(200101)90:1<1::AID-JPS1>3.0.CO;2-K · DOI
  8. Barandun, 1962, Intravenous administration of human gamma-globulin, Vox Sanguinis, 7, 157, 10.1111/j.1423-0410.1962.tb03240.x · DOI · Paper page
  9. Ellis, 1969, Adverse reactions following administration of human gamma globulin, J Allergy, 43, 45, 10.1016/0021-8707(69)90019-7 · DOI
  10. Schellekens, 2002, Bioequivalence and the immunogenicity of biopharmaceuticals, Nat Rev Drug Discov, 1, 457, 10.1038/nrd818 · DOI · Paper page
  11. Gershon, 2002, Pure red-cell aplasia and recombinant erythropoietin, N Engl J Med, 346, 1584, 10.1056/NEJM200205163462015 · DOI
  12. Casadevall, 2002, Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin, N Engl J Med, 346, 469, 10.1056/NEJMoa011931 · DOI · Paper page
  13. Sluzky, 1991, Kinetics of insulin aggregation in aqueous-solutions upon agitation in the presence of hydrophobic surfaces, Proc Natl Acad Sci USA, 88, 9377, 10.1073/pnas.88.21.9377 · DOI · Paper page
  14. Rathore, 2008, Current perspectives on stability of protein drug products during formulation, fill and finish operations, Biotechnol Prog, 24, 504, 10.1021/bp070462h · DOI · Paper page
  15. Seefeldt, 2007, Specific volume and adiabatic compressibility measurements of native and aggregated recombinant human interleukin-1 receptor antagonist: Density differences enable pressure-modulated refolding, Biotechnol Bioeng, 98, 476, 10.1002/bit.21398 · DOI
  16. Purohit, 2006, Influence of aggregation on immunogenicity of recombinant human factor VIII in hemophilia A mice, J Pharm Sci, 95, 358, 10.1002/jps.20529 · DOI
  17. Hermeling, 2005, Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b, Pharm Res, 22, 1997, 10.1007/s11095-005-8177-9 · DOI
  18. Hermeling, 2006, Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation, J Pharm Sci, 95, 1084, 10.1002/jps.20599 · DOI · Paper page
  19. St John, 1999, High pressure fosters protein refolding from aggregates at high concentrations, Proc Natl Acad Sci USA, 96, 13029, 10.1073/pnas.96.23.13029 · DOI · Paper page
  20. St John, 2001, High pressure refolding of recombinant human growth hormone from insoluble aggregates—Structural transformations, kinetic barriers, and energetics, J Biol Chem, 276, 46856, 10.1074/jbc.M107671200 · DOI
  21. Bugelski, 2004, Predictive power of preclinical studies of recombinant therapeutic proteins in animals for the immunogenicity humans, Curr Opin Mol Therap, 6, 10
  22. Babiuk, 2004, Aggregate content influences the Thl/Th2 immune response to influenza vaccine: Evidence from a mouse model, J Med Virol, 72, 138, 10.1002/jmv.10540 · DOI
  23. Hermeling, 2005, Development of a transgenic mouse model immune tolerant for human interferon beta, Pharm Res, 22, 847, 10.1007/s11095-005-4578-z · DOI
  24. Adkins, 2000, Exclusive Th2 primary effector function in spleens but mixed Th1/Th2 function in lymph nodes of murine neonates, J Immunol, 164, 2347, 10.4049/jimmunol.164.5.2347 · doi:10.4049/jimmunol.164.5.2347
  25. Adkins, 1999, T-cell function in newborn mice and humans, Immunol Today, 20, 330, 10.1016/S0167-5699(99)01473-5 · DOI · Paper page
  26. Singh, 1996, Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: Implications for antibody vs T cell-mediated autoimmunity, J Exp Med, 183, 1613, 10.1084/jem.183.4.1613 · DOI
  27. Petersen, 2006, Persistence of neutralizing antibodies after discontinuation of IFN beta therapy in patients with relapsing-remitting multiple sclerosis, Mult Scler, 12, 247, 10.1191/135248505ms1324oa · DOI
  28. Schellekens, 2004, Immunogenicity of recombinant human proteins: Causes and consequences, J Neurol, 251, 4, 10.1007/s00415-004-1202-9 · DOI · Paper page
  29. Polman, 2006, Neutralizing antibodies to interferon-beta may persist after cessation of therapy: What impact could they have?, Mult Scler, 12, 245, 10.1191/135248506ms1284ed · doi:10.1191/135248506ms1284ed
  30. Cleland, 1997, Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development, Adv Drug Deliv Rev, 28, 71, 10.1016/S0169-409X(97)00051-3 · DOI
  31. Whitmore, 2004, DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data, Nucleic Acids Res, 32, W668, 10.1093/nar/gkh371 · DOI · Paper page
  32. Maa, 1996, Aggregation of recombinant human growth hormone induced by phenolic compounds, Int J Pharm, 140, 155, 10.1016/0378-5173(96)04577-2 · DOI
  33. Kueltzo, 2003, Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: A bGCSF case study, J Pharm Sci, 92, 1805, 10.1002/jps.10439 · doi:10.1002/jps.10439
  34. Mach, 1994, Simultaneous monitoring of the environment of tryptophan, tyrosine, and phenylalanine residues in proteins by near-ultraviolet 2nd-derivative spectroscopy, Anal Biochem, 222, 323, 10.1006/abio.1994.1499 · DOI
  35. Galanaud, 1976, 2 processes for B-cell triggering by T-independent antigens as evidenced by effect of azathioprine, Cell Immunol, 22, 83, 10.1016/0008-8749(76)90009-5 · doi:10.1016/0008-8749(76)90009-5
  36. Dintzis, 1976, Molecular determinants of immunogenicity—Immunon model of immune-response, Proc Natl Acad Sci USA, 73, 3671, 10.1073/pnas.73.10.3671 · DOI · Paper page
  37. Yang, 2005, B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88, J Immunol, 174, 7912, 10.4049/jimmunol.174.12.7912 · DOI
  38. Bachmann, 1993, The influence of antigen organization on B-cell responsiveness, Science, 262, 1448, 10.1126/science.8248784 · DOI · Paper page
  39. De Groot, 2007, Immunogenicity of protein therapeutics, Trends Immunol, 28, 482, 10.1016/j.it.2007.07.011 · DOI · Paper page
  40. Friede, 2005, Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems, Adv Drug Deliv Rev, 57, 325, 10.1016/j.addr.2004.10.001 · DOI
  41. Bristow, 2001, The second international standard for somatropin (recombinant DNA-derived human growth hormone): Preparation and calibration in an international collaborative study, Biologicals, 29, 97, 10.1006/biol.2001.0281 · doi:10.1006/biol.2001.0281
  42. Hepner, 2006, Massspectrometrical analysis of recombinant human growth hormone Norditropin (R) reveals amino acid exchange at M14_V14 rhGH, Proteomics, 6, 775, 10.1002/pmic.200500334 · DOI
  43. Strasburger, 1990, Antigenic epitope mapping of the human growth-hormone molecule—A strategy to standardize growth-hormone immunoassays, Acta Paediatrica Scandinavica, 370, 82, 10.1111/j.1651-2227.1990.tb11679.x · doi:10.1111/j.1651-2227.1990.tb11679.x
  44. Nakashima, 1975, Adjuvant action of capsular polysaccharide of klebsiella-pneumoniae on antibody-response. 4. Roles of antigen and adjuvant for induction of primary and secondary antibody-responses and for development of immunological memory to bovine serum-albumin, Jpn J Microbiol, 19, 277, 10.1111/j.1348-0421.1975.tb00881.x · doi:10.1111/j.1348-0421.1975.tb00881.x
  45. Gammon, 1986, Induction of tolerance to one determinant on a synthetic peptide does not affect the response to a 2nd linked determinant—Implications for the mechanism of neonatal tolerance induction, J Exp Med, 164, 667, 10.1084/jem.164.2.667 · doi:10.1084/jem.164.2.667
  46. Clayton, 1989, Peptide-specific prevention of experimental allergic encephalomyelitis—Neonatal tolerance induced to the dominant T-cell determinant of myelin basic-protein, J Exp Med, 169, 1681, 10.1084/jem.169.5.1681 · DOI
  47. Billingham, 1953, Actively acquired tolerance of foreign cells, Nature, 172, 603, 10.1038/172603a0 · DOI · Paper page
  48. Gammon, 1986, Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation, Nature, 319, 413, 10.1038/319413a0 · doi:10.1038/319413a0
  49. Duclos, 1977, Suppressor T cells—Presence in mice rendered tolerant by neonatal treatment with anti-receptor antibody or antigen, J Immunol, 119, 1769, 10.4049/jimmunol.119.5.1769 · doi:10.4049/jimmunol.119.5.1769
  50. Maverakis, 2000, J Exp Med, 191, 695, 10.1084/jem.191.4.695 · doi:10.1084/jem.191.4.695
  51. Forsthuber, 1996, Induction of T(H)1 and T(H)2 immunity in neonatal mice, Science, 271, 1728, 10.1126/science.271.5256.1728 · DOI · Paper page
  52. Adkins, 2001, The generation of Th memory in neonates versus adults: Prolonged primary Th2 effector function and impaired development of Th1 memory effector function in murine neonates, J Immunol, 166, 918, 10.4049/jimmunol.166.2.918 · DOI
  53. Klitgaard, 2006, Reduced susceptibility of recombinant polyclonal antibodies to inhibitory anti-variable domain antibody responses, J Immunol, 177, 3782, 10.4049/jimmunol.177.6.3782 · DOI
  54. Saban, 1996, Erythroid-specific expression of human growth hormone affects bone morphology in transgenic mice, Bone, 18, 47, 10.1016/8756-3282(95)00419-X · DOI
  55. Rosenberg, 2004, A risk-based approach to immunogenicity concerns of therapeutic protein products. Part 1. Considering consequences of the immune response to a protein, Biopharm Int, 17, 22
  56. Thavasu, 1992, Measuring cytokine levels in blood—Importance of anticoagulants, processing, and storage-conditions, J Immunol Methods, 153, 115, 10.1016/0022-1759(92)90313-I · DOI · Paper page
  57. Casanueva, 1992, Physiology of growth-hormone secretion and action, Endocrinol Metab Clin N Am, 21, 483, 10.1016/S0889-8529(18)30199-3 · DOI · Paper page
  58. VanCauter, 1996, Physiology of growth hormone secretion during sleep, J Pediatr, 128, S32, 10.1016/S0022-3476(96)70008-2 · DOI · Paper page

Cited by

See all 170

Metadata

Authors
Fradkin, A. H., Carpenter, J. F., & Randolph, T. W.
Venue
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2009-09
Volume
98
Issue
9
Pages
3247-3264
ISSN
0022-3549 (ISSN-L)
OpenAlex
W1969652074
Cited by
170
References
3
FWCI
7.20
Type
journal article
Language
en
Open access
bronze
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunogenicity of aggregates of recombinant human growth hormone in mouse models. https://app.cochat.ai/papers/10.1002/jps.21834
The paper
Fradkin, A. H., Carpenter, J. F., & Randolph, T. W. (2009). Immunogenicity of aggregates of recombinant human growth hormone in mouse models. Journal of Pharmaceutical Sciences. https://doi.org/10.1002/jps.21834

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.